Tempest Therapeutics, Inc.
TPST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $302,737 | $67,831 | $13,276 | $1,536 |
| - Cash | $30,268 | $39,230 | $31,230 | $51,829 |
| + Debt | $15,365 | $20,661 | $22,114 | $18,537 |
| Enterprise Value | $287,834 | $49,262 | $4,160 | -$31,756 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$389 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$40,138 | -$27,661 | -$33,453 | -$26,646 |
| % Margin | – | – | – | – |
| Net Income | -$41,843 | -$29,491 | -$35,709 | -$28,302 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.5 | -1.91 | -3.18 | -7.8 |
| % Growth | 21.5% | 39.9% | 59.2% | – |
| Operating Cash Flow | -$33,027 | -$27,357 | -$31,072 | -$25,957 |
| Capital Expenditures | -$435 | -$170 | -$562 | -$135 |
| Free Cash Flow | -$33,462 | -$27,527 | -$31,634 | -$26,092 |